BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Godavari Drugs Ltd. Share Price

NSE
BSE

BSE : 530317

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

High

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 295.52 1567.12
Expenses N/A N/A
PBT 9.22 69.22
Operating profit 0.0 0.0
Net profit 7.67 55.49

Shareholding Pattern

Promoters (% Holding)

40.23%

Mutual funds (% Holding)

0.99%

Non-Institution (% Holding)

57.30%

FI/Banks/Insurance (% Holding)

0.37%

Government (% Holding)

0.00%

FII

0.00%

About Godavari Drugs Ltd.

Founded 1987
Managing Director Mukund Kakani

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,37,734.67 1,824.40 1,548.00 - 1,548.00
Divi's Laboratories Ltd. 1,80,311.57 6,789.10 5,636.50 - 5,636.50
Torrent Pharmaceuticals Ltd. 1,45,369.09 4,325.20 3,102.00 - 3,102.00
Apollo Hospitals Enterprise Ltd. 1,15,044.98 8,008.45 6,696.50 - 6,696.50
Cipla Ltd. 1,07,204.87 1,330.35 1,165.70 - 1,165.70
Dr. Reddy's Laboratories Ltd. 1,05,592.45 1,265.10 1,148.40 - 1,148.40
Lupin Ltd. 1,01,293.89 2,215.45 1,836.80 - 1,836.80
Max Healthcare Institute Ltd. 99,791.55 1,025.35 903.00 - 903.00
Mankind Pharma Ltd. 99,384.29 2,415.30 1,909.70 - 1,909.70
Zydus Lifesciences Ltd. 94,480.34 940.00 835.50 - 835.50
no-content No Records Found

Latest News

Apr
8
2026
EQUITY Posted on Apr 8th 2026

Godavari Drugs informs about certificate

Godavari Drugs has informed that it enclosed certificate issued by CIL Securities, Registrar and Share transfer Agent dated 07th April, 2026 confirming the compliance of regulation 74 (5) of SEBI (Depository and Participants) Regulations, 2018 for the quarter ended March 31, 2026.

The above information is a part of company’s filings submitted to BSE. 

Read More
Mar
23
2026
EQUITY Posted on Mar 23rd 2026

Godavari Drugs informs about trading window closure

Godavari Drugs has informed that the trading window for dealing in the Company's securities by its Designated persons and their Immediate Relatives will remain closed from Wednesday, April 01, 2026 till 48 hours after the declaration of the Audited Financial Results for the quarter and financial year ending March 31, 2026. Further, the date of the Board Meeting for consideration and approval of Audited Financial Results of the Company for the quarter and financial year ending March 31, 2026 shall be intimated to the Stock Exchange in due course of time.
The above information is a part of company’s filings submitted to BSE.
Read More
Mar
23
2026
EQUITY Posted on Mar 23rd 2026

Godavari Drugs informs about disclosures

Godavari Drugs has informed that the Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Prashant Shrimal.
The above information is a part of company’s filings submitted to BSE.
Read More
May
13
2026
EQUITY Posted on May 13th 2026

Emmessar Biotech & Nutrition informs about press release

Emmessar Biotech & Nutrition has informed that it enclosed copies of Audited Financial Results of the Company for the quarter and financial year ended March 31, 2026 published in today’s newspapers in Free Press Journal and Nav Shakti in accordance with Regulation 47 of the Listing Regulations.
The above information is a part of company’s filings submitted to BSE.
Read More
May
13
2026
EQUITY Posted on May 13th 2026

Zydus Lifesciences informs about update on board meeting

Zydus Lifesciences has informed that this is in furtherance of earlier intimation dated May 8, 2026, about the meeting of the Board of Zydus Lifesciences (the Company) scheduled to be held on Tuesday, May 19, 2026. In terms of Regulation 29(1)(b) and Regulation 29(2) of the Listing Regulations, the Board of the Company, at its aforesaid meeting, will also consider the proposal for buyback of fully paid-up equity shares of the Company and the matters necessary and incidental thereto, in accordance with the applicable provisions under the Companies Act, 2013, as amended, (including the rules and regulations framed thereunder), the Securities and Exchange Board of India (Buy-back of Securities) Regulations, 2018, as amended, and other applicable laws. As intimated earlier, the trading window as per the SEBI (Prohibition of Insider Trading) Regulations, 2015 shall remain closed till Thursday, May 21, 2026, and shall open for trading on and from Friday, May 22, 2026, for all the Directors and Designated Persons of the Company. The trading window shall be deemed to be closed in respect of the aforementioned buyback proposal as well, in accordance with applicable laws.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Godavari Drugs Ltd. ?

The current share price of Godavari Drugs Ltd. is ₹129.35 as of 2026-05-13.

The market capitalisation of Godavari Drugs Ltd. is ₹131.00 as of 2026-05-13.

The 1-year return of Godavari Drugs Ltd. is 35.38% as of 2026-05-13.

The P/E ratio of Godavari Drugs Ltd. is 15.04 as of 2026-05-14.

The 52-week high and low of Godavari Drugs Ltd. are ₹134.50 and ₹69.70, respectively, as of 2026-05-13.

The dividend yield of Godavari Drugs Ltd. is 0.0% as of2026-05-13.

You can buy Godavari Drugs Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Godavari Drugs Ltd. is Mukund Kakani.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore